1
Yong Zhao, Min Chu, Jian lai Zhou, Lijuan Wang: Refining of segmental boundaries in speech waveforms using contextual-dependent models. Microsoft Corporation, Steven M Koehler, Westman Champlin & Kelly P A, February 24, 2009: US07496512 (138 worldwide citation)

A method and apparatus are provided for refining segmental boundaries in speech waveforms. Contextual acoustic feature similarities are used as a basis for clustering adjacent phoneme speech units, where each adjacent pair phoneme speech units include a segmental boundary. A refining model is traine ...


2
Lijuan Wang, Lei Ma, Frank Kao Ping Soong: Speech and text driven HMM-based body animation synthesis. Microsoft Corporation, Lyon & Harr, Mark A Watson, July 17, 2012: US08224652 (51 worldwide citation)

An “Animation Synthesizer” uses trainable probabilistic models, such as Hidden Markov Models (HMM), Artificial Neural Networks (ANN), etc., to provide speech and text driven body animation synthesis. Probabilistic models are trained using synchronized motion and speech inputs (e.g., live or recorded ...


3
Dennis L Bidney, Sean Coughlan, Craig Hastings, Christopher J Scelonge, Lijuan Wang: Sunflower seeds with enhanced saturated fatty acid contents. Pioneer Hi Bred International, Foley & Lardner, July 4, 2000: US06084164 (32 worldwide citation)

Antisense expression of a stearoyl-ACP desaturase gene in sunflower results in more than a four-fold increase in seed stearate, and can enhance palmitate content as well. Thus, sunflower oil containing over 40 percent saturated fatty acids can be produced, which is desirable in the context of variou ...


4
James A Sikorski, Richard C Durley, Deborah A Mischke, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Margaret L Grapperhaus, Brian S Hickory, Mark A Massa, Monica B Norton, William F Vernier, Barry L Parnas, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity. G D Searle & Co, J Timothy Keane, October 1, 2002: US06458803 (17 worldwide citation)

The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery di ...


5
James A Sikorski, Richard C Durley, Deborah A Mischke, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Margaret L Grapperhaus, Brian S Hickory, Mark A Massa, Monica B Norton, William F Vernier, Barry L Parnas, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity. G D Searle & Co, J Timothy Keane, November 5, 2002: US06476075 (13 worldwide citation)

The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery di ...


6
James A Sikorski, Richard C Durley, Margaret L Grapperhaus, Mark A Massa, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Brian S Hickory, Monica B Norton, William F Vernier, Deborah A Mischke, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity. Pharmacia Corporation, J Timothy Keane, April 20, 2004: US06723752 (12 worldwide citation)

The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1 )-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and ...


7
William Gordan Kamm, Dorothy A Pierce, Benjamin Bowen, Dennis Bidney, Margit Ross, Christopher Scelonge, Michael D Miller, Gary Sandahl, Lijuan Wang: Use of the green fluorescent protein as a screenable marker for plant transformation. Pioneer Hi Bred International, Pioneer Hi Bred International, November 26, 2002: US06486382 (11 worldwide citation)

A method for the production of transgenic plants is provided in which a vector carrying a gene encoding the green fluorescent protein is introduced into cells, the cells are screened for the protein and transformed cells are selected and regenerated. The cellular toxicity of the green fluorescent pr ...


8
James A Sikorski, Richard C Durley, Deborah A Mischke, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Margaret L Grapperhaus, Brian S Hickory, Mark A Massa, Monica B Norton, William F Vernier, Barry L Parnas, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity. Pharmacia Corporation, J Timothy Keane, March 23, 2004: US06710089 (10 worldwide citation)

The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery di ...


9
James A Sikorski, Richard C Durley, Deborah A Mischke, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Margaret L Grapperhaus, Brian S Hickory, Mark A Massa, Monica B Norton, William F Vernier, Barry L Parnas, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity. G D Searle & Co, J Timothy Keane, October 8, 2002: US06462092 (10 worldwide citation)

The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary ar ...


10
James A Sikorski, Richard C Durley, Deborah A Mischke, Emily J Reinhard, Yvette M Fobian, Michael B Tollefson, Lijuan Wang, Margaret L Grapperhaus, Brian S Hickory, Mark A Massa, Monica B Norton, William F Vernier, Barry L Parnas, Michele A Promo, Ashton T Hamme, Dale P Spangler, Melvin L Rueppel: Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity. Pharmacia Corporation, J Timothy Keane, January 27, 2004: US06683099 (9 worldwide citation)

The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery di ...